<DOC>
	<DOCNO>NCT00190034</DOCNO>
	<brief_summary>The purpose study determine whether N-acetylcysteine effective prophylaxis post-cardiopulmonary bypass acute renal impairment .</brief_summary>
	<brief_title>Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass .</brief_title>
	<detailed_description>BACKGROUND Reactive oxygen specie show cause contrast-induced nephrotoxicity ( CIN ) . According previous study , N-acetylcysteine prove advantageous avoidance CIN . We seek evaluate efficacy antioxidant N-acetylcysteine limit nephrotoxicity cardiovascular surgery cardiopulmonary bypass . METHODS We prospectively study 60 patient receive cardiovascular surgery cardiopulmonary bypass . Patients randomly assign receive either N-acetylcysteine ( 600 mg orally twice daily 4 dos ) 0.45 % saline intravenously , cardiopulmonary bypass , placebo 0.45 % saline . Serum creatinine blood urea nitrogen measure , 48 h 5 day operation procedure . Expected result Prophylactic oral administration antioxidant N-acetylcysteine , along hydration , significantly reduce acute renal damage induce CPB patient chronic renal insufficiency need cardiovascular procedure .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>All patient receive cardiac surgery cardiopulmonary bypass 1 . Dialyzed patient 2 . Acute renal failure 3 . Advanced leave ventricular systolic dysfunction define leave ventricular ejection fraction â‰¦ 35 % . 4 . Acute chronic obstructive lung disease asthma exacerbation 5 . Allergy Nacetylcysteine</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Acetylcysteine</keyword>
	<keyword>cardiac surgery</keyword>
	<keyword>cardiopulmonary bypass</keyword>
	<keyword>acute renal insufficiency</keyword>
</DOC>